AstraZeneca delivered a strong performance in Q4 2024, with Total Revenue reaching $14.89 billion, marking a 24%...
South Korea-based Hanmi Pharmaceutical's Global Business Headquarters Overseas Sales Team is making significant strides ...
Qiagen has announced the official opening of a new data centre in Melbourne, Australia, designed to strengthen its globa...
South Korea-based SK bioscience has announced that it is the only private company to participate in the World Health Org...
ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimise ...
India-based Zydus Lifesciences (including its subsidiaries and affiliates), has signed an exclusive development, licensi...
Bio X Cell, the world's leading provider of functional antibodies for translational research, is strengthening its globa...
AdvanCell, a radiopharmaceutical company specialising in targeted alphaherapias, has announced the expansion of the scop...
South Korea-based OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced a global licensing...
Japan-based PHC Corporation has signed a Master Collaboration Agreement with CCRM (based in Canada) to work together on ...
LG AI Research recently signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu,&...
Bain Capital, a leading global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe P...
Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of India-based Dr. Reddy’s Laboratories Ltd. has entere...
BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in the US, has announ...
US-based ValGenesis Inc., the global leader in enterprise validation lifecycle management systems (VLMS), and Hitachi In...
Gene Solutions (GS), a pioneer genomic testing company in South-East Asia, aims to introduce a smart blood test to ...
MediBuddy, India's largest digital healthcare company, has announced a strategic partnership with ELECOM, a leading Japa...
Clinically, Alexion has made substantial strides in the treatment of rare and debilitating conditions. A...
Beam Therapeutics, a leader in the gene-editing field, continues to make significant progress in its mission to ...
Argenx, a global leader in immunology, has made significant strides in 2024, bolstering its position as a pioneer in the...
Bluebird Bio, a pioneering company in the gene therapy sector, has made significant strides in 2024, showcasing both ope...
Alnylam Pharmaceuticals achieved significant progress in both its scientific and commercial ...
Novavax made significant strides in advancing its vaccine portfolio while solidifying its financial and operatio...
Vertex Pharmaceuticals made substantial strides in its therapeutic pipeline, achieved key regulatory approvals, ...
Sarepta Therapeutics achieved remarkable milestones in gene therapy and muscular dystrophy treatments during the first h...
